Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04253561
Title Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (IPATHER)
Acronym IPATHER
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors SOLTI Breast Cancer Research Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
ICO Badalona NOT_YET_RECRUITING Badalona Barcelona Spain Details
Comp. Hosp.Univ. Santiago (Chus) NOT_YET_RECRUITING Santiago De Compostela La Coruña Spain Details
Hospital Universitario del Vall d' Hebron RECRUITING Barcelona Spain Details
H.Univ. Arnau de Vilanova de Lleida NOT_YET_RECRUITING Lleida Spain Details
Centro Integral Oncológico Clara Campal (CIOCC) NOT_YET_RECRUITING Madrid Spain Details
Hospital Universitario Doce de Octubre RECRUITING Madrid Spain Details
MD Anderson NOT_YET_RECRUITING Madrid Spain Details
Hospital Universitario Virgen del Rocio NOT_YET_RECRUITING Sevilla Spain Details
Hospital Virgen de Macarena NOT_YET_RECRUITING Sevilla Spain Details
Fundación Instituto Valenciano de Oncología RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field